Abdollahi, M., Sefidkon, F., Calagari, M., Mousavi, A., and Mahomoodally, M. F. 2020. A comparative study of seed yield and oil composition of four cultivars of Hemp (Cannabis sativa L.) grown from three regions in northern Iran. Industrial Crops and Products, 152: 112397.

Abi-Jaoude, E., Chen, L., Cheung, P., Bhikram, T. and Sandor, P. 2017. Preliminary evidence on cannabis effectiveness and tolerability for adults with Tourette syndrome. The Journal of Neuropsychiatry and Clinical Neurosciences, 29 (4): 391-400.

Ahmed, A. I. A., Van Der Marck, M. A., Van Den Elsen, G. A. H. and Olde Rikkert, M. G. M., 2015. Cannabinoids in late-onset Alzheimer’s disease. Clinical Pharmacology and Therapeutics, 97: 597-606.

Almogi-Hazan, O. and Or, R. 2020. Cannabis, the Endocannabinoid System and Immunity-the Journey from the Bedside to the Bench and Back. International Journal of Molecular Sciences, 21 (12): 4448.

Amini-Lari, M., Wang, L., Neumark, S., Adli, T., Couban, R. J., Giangregorio, A., Carney, C. E. and Busse, J. W. 2022. Medical cannabis and cannabinoids for impaired sleep: a systematic review and meta-analysis of randomized clinical trials. Sleep, 45 (2): 117-128.

Archibald, P. C. and Thorpe Jr, R. J. 2021. Life Stressors and sleep problems as predictors of the likelihood of lifetime cannabis use among Black adults with criminal justice contact. Ethnicity and Disease, 31 (2): 187.

Asadi, S., Moghadam, H., Naghdi Badi, H., Naghavi, M., Salami, S. 2019. A review on agronomic, phytochemical and pharmacological aspects of cannabis (Cannabis sativa L.). Journal of Medicinal Plants, 18 (70): 1-20.

Aso, E. and Ferrer, I. 2016. CB2 cannabinoid receptor as potential target against Alzheimer's disease. Frontiers in Neuroscience, 10: 243.

Aymerich, M. S., Aso, E., Abellanas, M. A., Tolon, R. M., Ramos, J. A., Ferrer, I., Romero, J. and Fernández-Ruiz, J., 2018. Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system. Biochemical Pharmacology, 157: 67-84.

Babaei, M., and Ajdanian, L. 2020. Screening of different Iranian ecotypes of cannabis under water deficit stress. Scientia Horticulturae, 260: 108904.

Babson, K. A., Sottile, J. and Morabito, D. 2017. Cannabis, cannabinoids, and sleep: a review of the literature. Current Psychiatry Reports, 19 (4): 1-12.

Badowski, M. E. 2017. A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics. Cancer Chemotherapy and Pharmacology, 80 (3): 441-449.

Badowski, M. E. and Perez, S. E. 2016. Clinical utility of dronabinol in the treatment of weight loss associated with HIV and AIDS. HIV/AIDS - Research and Palliative Care, 8: 37-45.

Bilkei-Gorzo, A., Albayram, O., Draffehn, A., Michel, K., Piyanova, A., Oppenheimer, H., Dvir-Ginzberg, M., Rácz, I., Ulas, T., Imbeault, S. and Bab, I. 2017. A chronic low dose of Δ 9-tetrahydrocannabinol (THC) restores cognitive function in old mice. Nature Medicine, 23 (6): 782-787.

Billnitzer, A. and Jankovic, J. 2020. Current management of tics and Tourette syndrome: behavioral, pharmacologic, and surgical treatments. Neurotherapeutics, 17: 1681-1693.

Blake, A., Wan, B. A., Malek, L., DeAngelis, C., Diaz, P., Lao, N., Chow, E. and O'Hearn, S. 2017. A selective review of medical cannabis in cancer pain management. Annals of Palliative Medicine, 6 (Suppl 2): S215-S222.

Bonini, S. A., Premoli, M., Tambaro, S., Kumar, A., Maccarinelli, G., Memo, M. and Mastinu, A. 2018. Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. Journal of Ethnopharmacology, 227: 300-315.

Booth, J. K. and Bohlmann, J. 2019. Terpenes in Cannabis sativa-From plant genome to humans. Plant Science, 284: 67-72.

Borna, T., Salami, S. A. and Shokrpour, M. 2017. High resolution melting curve analysis revealed SNPs in major cannabinoid genes associated with drug and non-drug types of cannabis. Biotechnology and Biotechnological Equipment, 31 (4): 839-845.

Botsford, S. L., Yang, S. and George, T. P., 2020. Cannabis and cannabinoids in mood and anxiety disorders: impact on illness onset and course, and assessment of therapeutic potential. American Journal on Addictions, 29: 9-26.

Bridgeman, M. B. and Abazia, D. T. 2017. Medicinal cannabis: history, pharmacology, and implications for the acute care setting. Pharmacy and Therapeutics, 42 (3): 180.

Brousseau, V. D., Wu, B. S., MacPherson, S., Morello, V. and Lefsrud, M. 2021. Cannabinoids and Terpenes: How Production of Photo-Protectants Can Be Manipulated to Enhance Cannabis sativa L. Phytochemistry. Frontiers in Plant Science, 12: 620021.

Brown, D. T. (Ed.). 1998. Cannabis: The Genus Cannabis. CRC Press, 277 pp.

Calik, M. W. and Carley, D. W. 2017. Effects of cannabinoid agonists and antagonists on sleep and breathing in Sprague-Dawley rats. Sleep, 40 (9): 1-8.

Cleeland, C. and Ryan, K. 1994. Pain assessment: global use of the Brief Pain Inventory. Annals, Academy of Medicine, 23 (2): 129-138.

Crispim Massuela, D., Hartung, J., Munz, S., Erpenbach, F. and Graeff-Hönninger, S. 2022. Impact of harvest time and pruning technique on total cbd concentration and yield of medicinal cannabis. Plants, 11 (1): 140.

Crocq, M. A. 2020. History of cannabis and the endocannabinoid system. Dialogues in Clinical Neuroscience, 22 (3): 223.

Currais, A., Quehenberger, O., M Armando, A., Daugherty, D., Maher, P. and Schubert, D. 2016. Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids. NPJ Aging and Mechanisms of Disease, 2 (1): 1-8.

Duggan, P. J. 2021. The chemistry of cannabis and cannabinoids. Australian Journal of Chemistry, 74 (6): 369-387.

ElSohly, M. A., Chandra, S., Radwan, M., Majumdar, C. G. and Church, J. C. 2021. A comprehensive review of cannabis potency in the United States in the last decade. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 6 (6): 603-606.

ElSohly, M. A., Radwan, M. M., Gul, W., Chandra, S. and Galal, A. 2017. Phytochemistry of Cannabis sativa L. Progress in the Chemistry of Organic Natural Products, 103: 1-36.

FDA, 2020. FDA and Cannabis: Research and Drug Approval Process. Retrieved from: https://www.fda.gov.

Fernández‐Ruiz, J. 2019. The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid‐based therapies to improve on the poor current therapeutic outcomes. British Journal of Pharmacology, 176 (10): 1370-1383.

Friedman, D., French, J. A. and Maccarrone, M. 2019. Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders. Lancet Neurol, 18: 504-512.

Fusar-Poli, P., Crippa, J. A., Bhattacharyya, S., Borgwardt, S. J., Allen, P., Martin-Santos, R., Seal, M., Surguladze, S. A., O’Carrol, C., Atakan, Z. and Zuardi, A. W. 2009. Distinct effects of Δ9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Archives of General Psychiatry, 66 (1): 95-105.

Grotenhermen, F. and Müller-Vahl, K. 2012. The therapeutic potential of cannabis and cannabinoids. Deutsches Ärzteblatt International, 109 (29-30): 495.

Haagen-Smit, A. J., Wawra, C. Z., Koepfli, J. B., Alles, G. A., Feigen, G. A. and Prater, A. N. 1940. A physiologically active principle from Cannabis sativa (marihuana). Science, 91 (2373): 602-603.

Hakimizadeh, E., Oryan, S., Hajizadeh Moghaddam, A., Shamsizadeh, A. and Roohbakhsh, A. 2012. Endocannabinoid System and TRPV1 receptors in the dorsal hippocampus of the rats modulate anxiety-like behaviors. Iranian Journal of Basic Medical Sciences, 15 (3): 795-802.

Haney, M. 2022. Cannabis use and the endocannabinoid system: a clinical perspective. American Journal of Psychiatry, 179 (1): 21-25.

Hanuš, L. O. and Hod, Y. 2020. Terpenes/terpenoids in cannabis: are they important? Medical Cannabis and Cannabinoids, 3 (1): 25-60.

Harvey, B. S., Ohlsson, K. S., Mååg, J. L., Musgrave, I. F. and Smid, S. D. 2012. Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro. Neurotoxicology, 33 (1): 138-146.

Horn, H., Böhme, B., Dietrich, L. and Koch, M. 2018. Endocannabinoids in body weight control. Pharmaceuticals, 11 (2): 55.

Huntsman, R. J., Tang-Wai, R. and Shackelford, A. E. 2020. Cannabis for pediatric epilepsy. Journal of Clinical Neurophysiology, 37 (1): 2-8.

Jakubovski, E. and Müller-Vahl, K. 2017. Speechlessness in Gilles de la Tourette syndrome: cannabis-based medicines improve severe vocal blocking tics in two patients. International Journal of Molecular Sciences, 18 (8): 1739.

Johnson, J. R., Burnell-Nugent, M., Lossignol, D., Ganae-Motan, E. D., Potts, R. and Fallon, M. T. 2010. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC: CBD extract and THC extract in patients with intractable cancer-related pain. Journal of Pain and Symptom Management, 39 (2): 167-179.

Karche, T. 2019. The application of hemp (Cannabis sativa L.) for a green economy: a review. Turkish Journal of Botany, 43 (6): 710-723.

Livingston, S. J., Quilichini, T. D., Booth, J. K., Wong, D. C., Rensing, K. H., Laflamme-Yonkman, J., Castellarin, S. D., Bohlmann, J., Page, J. E. and Samuels, A. L. 2020. Cannabis glandular trichomes alter morphology and metabolite content during flower maturation. The Plant Journal, 101 (1): 37-56.

Loewe, S. 1944. The marihuana problems in the city of New York (ed). The Mayor's Committee on Marihuana. Jacques Cattel Press, Lancaster. pp. 149-212.

Loewe, S. 1946. Studies on the pharmacology and acute toxicity of compounds with marihuana activity. Journal of Pharmacology and Experimental Therapeutics, 88 (2): 154-161.

Mastinu, A., Premoli, M., Ferrari-Toninelli, G., Tambaro, S., Maccarinelli, G., Memo, M. and Bonini, S. A. 2018. Cannabinoids in health and disease: Pharmacological potential in metabolic syndrome and neuroinflammation. Hormone Molecular Biology and Clinical Investigation, 36 (2): 1-15.

McPartland, J. M. 2018. Cannabis systematics at the levels of family, genus, and species. Cannabis and Cannabinoid Research, 3 (1): 203-212.

Mechoulam, R., Fride, E. and Di Marzo, V. 1998. Endocannabinoids. European Journal of Pharmacology, 359 (1): 1-18.

Messina, F., Rosati, O., Curini, M. and Marcotullio, M. C. 2015. Cannabis and bioactive cannabinoids. Studies in Natural Products Chemistry, 45: 17-57.

Moghaddam, A. H., Bigdellu, R., Tabatabaei, S. R. F. and Roohbakhsh, A. 2013. Cannabinoid system of the lateral septum in the modulation of anxiety-like behaviors in rats. Archives of Iranian Medicine, 16 (12): 711-717.

Mostafaei Dehnavi, M., Ebadi, A., Peirovi, A., Taylor, G. and Salami, S. A. 2022. THC and CBD fingerprinting of an elite cannabis collection from Iran: quantifying diversity to underpin future cannabis breeding. Plants, 11 (1): 129.

Müller-Vahl, K. 2021. Case in context: Tourette syndrome. Cannabis and Cannabinoid Research, 6 (2): 88-91.

Pakdaman, H., Harandi, A. A., Gharagozli, K., Alaeddini, F., Esfandani, A., Mirbehbahani, S. H. and Kazemi, H. 2021. Epilepsy lifetime prevalence in Iran: a large population-based national survey. Scientific Reports, 11 (1): 1-9.

Parsons, J. L., Martin, S. L., James, T., Golenia, G., Boudko, E. A. and Hepworth, S. R. 2019. Polyploidization for the genetic improvement of Cannabis sativa. Frontiers in Plant Science, 10 (476): 1-12.

Patton, G. C., Coffey, C., Carlin, J. B., Degenhardt, L., Lynskey, M. and Hall, W. 2002. Cannabis use and mental health in young people: cohort study. BMJ, 325 (7374): 1195-1198.

Paul, R., Williams, R., Hodson, V. and Peake, C. 2019. Detection of cannabinoids in hair after cosmetic application of hemp oil. Scientific Reports, 9 (1): 1-6.

Pejić, B. M., Kramar, A. D., Obradović, B. M., Kuraica, M. M., Žekić, A. A. and Kostić, M. M. 2020. Effect of plasma treatment on chemical composition, structure and sorption properties of lignocellulosic hemp fibers (Cannabis sativa L.). Carbohydrate Polymers, 236: 116000.

Peralta, J. 2019. Why CBD gummies were google's no. 3 food search term in 2018. Retrieved from: https://weedmaps.com.

Pertwee, R. G. 2006. Cannabinoid pharmacology: the first 66 years. British Journal of Pharmacology, 147 (S1): S163-S171.

Pisanti, S. and Bifulco, M. 2019. Medical Cannabis: A plurimillennial history of an evergreen. Journal of Cellular Physiology, 234 (6): 8342-8351.

Portenoy, R. K., Ganae-Motan, E. D., Allende, S., Yanagihara, R., Shaiova, L., Weinstein, S., McQuade, R., Wright, S. and Fallon, M. T. 2012. Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial. The Journal of Pain, 13 (5): 438-449.

Radwan, M. M., Chandra, S., Gul, S. and ElSohly, M. A. 2021. Cannabinoids, phenolics, terpenes and alkaloids of cannabis. Molecules, 26 (9): 2774.

Rahimi, A., Hajizadeh Moghaddam, A. and Roohbakhsh, A. 2015. Central administration of GPR 55 receptor agonist and antagonist modulates anxiety‐related behaviors in rats. Fundamental and Clinical Pharmacology, 29 (2): 185-190.

Raman, V., Lata, H., Chandra, S., Khan, I. A. and ElSohly, M. A. 2017. Morpho-anatomy of Marijuana (Cannabis sativa L.). In Cannabis sativa L.-Botany and Biotechnology (pp. 123-136). Springer, Cham.

Ramar, K., Rosen, I. M., Kirsch, D. B., Chervin, R. D., Carden, K. A., Aurora, R. N., Kristo, D. A., Malhotra, R. K., Martin, J. L., Olson, E. J. and Rosen, C. L. 2018. Medical cannabis and the treatment of obstructive sleep apnea: an American Academy of Sleep Medicine position statement. Journal of Clinical Sleep Medicine, 14 (4): 679-681.

Rasera, G. B., Ohara, A. and de Castro, R. J. S. 2021. Innovative and emerging applications of cannabis in food and beverage products: From an illicit drug to a potential ingredient for health promotion. Trends in Food Science and Technology, 115: 31-41.

Ren, G., Zhang, X., Li, Y., Ridout, K., Serrano-Serrano, M. L., Yang, Y., Liu, A., Ravikanth, G., Nawaz, M. A., Mumtaz, A. S. and Salamin, N. 2021. Large-scale whole-genome resequencing unravels the domestication history of Cannabis sativa. Science Advances, 7 (29): eabg2286.

Riahi, L., Shokrpour, M., Salami, S. A. and Khandan, A. 2016. Some quantitative traits associations and their application in characterization of Iranian accessions of Cannabis (Cannabis sativa L.). Iranian Journal of Field Crop Science, 46 (4): 629-639.

Roohbakhsh, A., Keshavarz, S., Hasanein, P., Rezvani, M. E. and Moghaddam, A. H. 2009. Role of endocannabinoid system in the ventral hippocampus of rats in the modulation of anxiety‐like behaviours. Basic and Clinical Pharmacology and Toxicology, 105 (5): 333-338.

Roohbakhsh, A., Moghaddam, A. H., Massoudi, R. and Zarrindast, M. R. 2007. Role of dorsal hippocampal cannabinoid receptors and nitric oxide in anxiety-like behaviours in rats using the elevated plus‐maze test. Clinical and Experimental Pharmacology and Physiology, 34 (3): 223-229.

Rostam-Abadi, Y., Gholami, J., Amin-Esmaeili, M., Baheshmat, S., Hamzehzadeh, M., Rafiemanesh, H., Nasserbakht, M., Ghalichi, L., Safarcherati, A., Taremian, F. and Mojtabai, R. 2021. Evidence for an increase in cannabis use in Iran-A systematic review and trend analysis. PloSOne, 16 (8): e0256563.

Salami, S. A., Martinelli, F., Giovino, A., Bachari, A., Arad, N. and Mantri, N. 2020. It is our turn to get cannabis high: Put cannabinoids in food and health baskets. Molecules, 25 (18): 4036.

Sanders, T. and Lewis, F. 2003. Review of nutritional attributes of good oil (cold pressed hemp seed oil). Geneva: WHO Technical Report Series, 9 pp.

Sarma, N. D., Waye, A., ElSohly, M. A., Brown, P. N., Elzinga, S., Johnson, H. E., Marles, R. J., Melanson, J. E., Russo, E., Deyton, L. and Hudalla, C. 2020. Cannabis inflorescence for medical purposes: usp considerations for quality attributes. Journal of Natural Products, 83 (4): 1334-1351.

Sartori, S. B. and Singewald, N. 2019. Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders. Pharmacology and Therapeutics. 39 (3): 272-279.

Scherma, M., Satta, V., Collu, R., Boi, M. F., Usai, P., Fratta, W. and Fadda, P. 2017. Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity‐based anorexia. British Journal of Pharmacology, 174 (16): 2682-2695.

Schug, S. A. and C. Chandrasena 2015. Pain management of the cancer patient. Expert Opinion on Pharmacotherapy, 16 (1): 5-15.

Shams, R., Azizi, A., Hamzei, J., Noroozisharaf, A., Moghadam, S. and Kordrostami, M. 2020. Genetic structure and diversity of Iranian Cannabis populations based on phytochemical, agro-morphological and molecular markers. Industrial Crops and Products, 158: 112950.

Silver, R. 2021. The Endocannabinoid System and Endocannabinoidome. in Cannabis Therapy in Veterinary Medicine. Springer, Cham. pp. 1-16.

Silver, R. J. 2019. The endocannabinoid system of animals. Animals, 9 (9): 686.

Slawek, D. E., Curtis, S. A., Arnsten, J. H. and Cunningham, C. O. 2022. Clinical approaches to cannabis: a narrative review. Medical Clinics, 106 (1): 131-152.

Sommano, S. R., Chittasupho, C., Ruksiriwanich, W. and Jantrawut, P. 2020. The cannabis terpenes. Molecules, 25 (24): 5792.

Soorani, A., Fatahi, R., Haak, D. C., Salami, S. A. and Bombarely, A. 2017. Assessment of genetic diversity and population structure in Iranian cannabis germplasm. Scientific reports, 7 (1): 1-10.

Sorrentino, G. 2021. Introduction to emerging industrial applications of cannabis (Cannabis sativa L.). Rendiconti Lincei. Scienze Fisiche e Naturali, 32 (2): 233-243.

Stith, S. S., Li, X., Orozco, J., Lopez, V., Brockelman, F., Keeling, K., Hall, B. and Vigil, J. M. 2022. The effectiveness of common cannabis products for treatment of nausea. Journal of Clinical Gastroenterology, 56 (4): 331-338.

Strzelczyk, M., Lochynska, M. and Chudy, M. 2021. Systematics and botanical characteristics of industrial hemp Cannabis sativa L., Journal of Natural Fibers, 19 (13): 1-23.

Suliman, N. A., Taib, C. N. M., Moklas, M. A. M. and Basir, R. 2018. Delta-9-tetrahydrocannabinol (∆ 9-THC) induce neurogenesis and improve cognitive performances of male Sprague Dawley rats. Neurotoxicity Research, 33 (2): 402-411.

Szaflarski, J. P., Bebin, E. M., Cutter, G., DeWolfe, J., Dure, L. S., Gaston, T. E., Kankirawatana, P., Liu, Y., Singh, R., Standaert, D. G. and Thomas, A. E. 2018. Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study. Epilepsy and Behavior, 87: 131-136.

Szejko, N., Saramak, K., Lombroso, A. and Müller-Vahl, K. 2022. Cannabis-based medicine in treatment of patients with Gilles de la Tourette syndrome. Neurologia i Neurochirurgia Polska, 56 (1): 28-38.

Thaler, A., Arad, S., Schleider, L. B. L., Knaani, J., Taichman, T., Giladi, N. and Gurevich, T. 2019. Single center experience with medical cannabis in Gilles de la Tourette syndrome. Parkinsonism and Related Disorders, 61: 211-213.

Thiele, E. A., Bebin, E. M., Filloux, F., Kwan, P., Loftus, R., Sahebkar, F., Sparagana, S. and Wheless, J. 2022. Long‐term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open‐label extension trial. Epilepsia, 63 (2): 426-439.

Thomas, B. F. and Elsohly, M. 2015. The analytical chemistry of cannabis: Quality assessment, assurance, and regulation of medicinal marijuana and cannabinoid preparations. Elsevier, pp. 121.

Toth, J. A., Stack, G. M., Cala, A. R., Carlson, C. H., Wilk, R. L., Crawford, J. L., Viands, D. R., Philippe, G., Smart, C. D., Rose, J. K. and Smart, L. B. 2020. Development and validation of genetic markers for sex and cannabinoid chemotype in Cannabis sativa L., Gcb Bioenergy, 12 (3): 213-222.

Tzadok, M., Uliel-Siboni, S., Linder, I., Kramer, U., Epstein, O., Menascu, S., Nissenkorn, A., Yosef, O. B., Hyman, E., Granot, D., Dor, M., Lerman-Sagie, T. and Ben-Zeev, B., 2016. CBD-enriched medical cannabis for intractable pediatric epilepsy: the current Israeli experience. Seizure, 35: 41-44.

Väisänen, T., Batello, P., Lappalainen, R. and Tomppo, L. 2018. Modification of hemp fibers (Cannabis sativa L.) for composite applications. Industrial Crops and Products, 111: 422-429.

Walther, S., Mahlberg, R., Eichmann, U. and Kunz, D. 2006. Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia. Psychopharmacology, 185 (4): 524-528.

Ward, S. J., McAllister, S. D., Kawamura, R., Murase, R., Neelakantan, H. and Walker, E. A. 2014. Cannabidiol inhibits paclitaxel‐induced neuropathic pain through 5‐HT1A receptors without diminishing nervous system function or chemotherapy efficacy. British Journal of Pharmacology, 171 (3): 636-645.

Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Her- nandez, A. V., Keurentjes, J. C., Lang, S., Misso, K., Ryder, S., Schmidlkofer, S., Westwood, M., Kleijnen, J., 2015. Cannabinoids for medical use: a systematic review and meta-analysis. Journal of the American Medical Association, 313: 2456-2473.

Woodward, M. R., Harper, D. G., Stolyar, A., Forester, B. P. and Ellison, J. M. 2014. Dronabinol for the treatment of agitation and aggressive behavior in acutely hospitalized severely demented patients with noncognitive behavioral symptoms. The American Journal of Geriatric Psychiatry, 22 (4): 415-419.

Yang, M. Q., van Velzen, R., Bakker, F. T., Sattarian, A., Li, D. Z., and Yi, T. S. 2013. Molecular phylogenetics and character evolution of Cannabaceae. Taxon, 62 (3): 473-485.

Zhang, S. D., Soltis, D. E., Yang, Y., Li, D. Z. and Yi, T. S. 2011. Multi-gene analysis provides a well-supported phylogeny of Rosales. Molecular Phylogenetics and Evolution, 60 (1): 21-28.

Zuardi, A. W. 2006. History of cannabis as a medicine: a review. Brazilian Journal of Psychiatry, 28: 153-157.

Zuk-Golaszewska, K., and Golaszewski, J. 2018. Cannabis sativa L.– Cultivation and quality of raw material. Journal of Elementology, 23 (3): 971-984.